159 related articles for article (PubMed ID: 34284074)
1. DRD1 agonist A-68930 improves mitochondrial dysfunction and cognitive deficits in a streptozotocin-induced mouse model.
Cheng ZY; Hu YH; Xia QP; Wang C; He L
Brain Res Bull; 2021 Oct; 175():136-149. PubMed ID: 34284074
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 receptor agonist A-68930 ameliorates Aβ
Cheng ZY; Xia QP; Hu YH; Wang C; He L
Int Immunopharmacol; 2020 Nov; 88():106963. PubMed ID: 33182028
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin Ameliorates Cognitive Impairments and Alzheimer's Disease-Like Pathology with Restoring Mitochondrial Abnormality in the Hippocampus of Streptozotocin-Induced Diabetic Mice.
Ding Y; Liu H; Cen M; Tao Y; Lai C; Tang Z
Neurochem Res; 2021 Feb; 46(2):265-275. PubMed ID: 33140268
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mTORC1 improves STZ-induced AD-like impairments in mice.
Cao Y; Liu B; Xu W; Wang L; Shi F; Li N; Lei Y; Wang J; Tian Q; Zhou X
Brain Res Bull; 2020 Sep; 162():166-179. PubMed ID: 32599128
[TBL] [Abstract][Full Text] [Related]
5. The ameliorative effects and underlying mechanisms of dopamine D1-like receptor agonist SKF38393 on Aβ
Zang X; Cheng ZY; Sun Y; Hua N; Zhu LH; He L
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():250-261. PubMed ID: 28939187
[TBL] [Abstract][Full Text] [Related]
6. Insulin deficiency, but not resistance, exaggerates cognitive deficits in transgenic mice expressing human amyloid and tau proteins. Reversal by Exendin-4 treatment.
King MR; Anderson NJ; Deciu M; Guernsey LS; Cundiff M; Hajizadeh S; Jolivalt CG
J Neurosci Res; 2020 Nov; 98(11):2357-2369. PubMed ID: 32737929
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
Wu X; Kosaraju J; Zhou W; Tam KY
ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
[TBL] [Abstract][Full Text] [Related]
9. Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.
Wang Y; Wu L; Li J; Fang D; Zhong C; Chen JX; Yan SS
J Alzheimers Dis; 2015; 43(2):451-63. PubMed ID: 25096625
[TBL] [Abstract][Full Text] [Related]
10. L-Stepholidine rescues memory deficit and synaptic plasticity in models of Alzheimer's disease via activating dopamine D1 receptor/PKA signaling pathway.
Hao JR; Sun N; Lei L; Li XY; Yao B; Sun K; Hu R; Zhang X; Shi XD; Gao C
Cell Death Dis; 2015 Nov; 6(11):e1965. PubMed ID: 26539912
[TBL] [Abstract][Full Text] [Related]
11. Dopamine D1 receptor agonism induces dynamin related protein-1 inhibition to improve mitochondrial biogenesis and dopaminergic neurogenesis in rat model of Parkinson's disease.
Mishra A; Singh S; Tiwari V; Bano S; Shukla S
Behav Brain Res; 2020 Jan; 378():112304. PubMed ID: 31626851
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
13. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
14. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
Sheng B; Wang X; Su B; Lee HG; Casadesus G; Perry G; Zhu X
J Neurochem; 2012 Feb; 120(3):419-29. PubMed ID: 22077634
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation.
Liu LP; Yan TH; Jiang LY; Hu W; Hu M; Wang C; Zhang Q; Long Y; Wang JQ; Li YQ; Hu M; Hong H
Acta Pharmacol Sin; 2013 Apr; 34(4):455-63. PubMed ID: 23524568
[TBL] [Abstract][Full Text] [Related]
16. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice.
Wang T; Nowrangi D; Yu L; Lu T; Tang J; Han B; Ding Y; Fu F; Zhang JH
J Neuroinflammation; 2018 Jan; 15(1):2. PubMed ID: 29301581
[TBL] [Abstract][Full Text] [Related]
17. PGC-1α overexpression exacerbates β-amyloid and tau deposition in a transgenic mouse model of Alzheimer's disease.
Dumont M; Stack C; Elipenahli C; Jainuddin S; Launay N; Gerges M; Starkova N; Starkov AA; Calingasan NY; Tampellini D; Pujol A; Beal MF
FASEB J; 2014 Apr; 28(4):1745-55. PubMed ID: 24398293
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptor alleviates doxorubicin-induced cardiac injury by inhibiting NLRP3 inflammasome.
Liu J; Jin Y; Wang B; Wang Y; Zuo S; Zhang J
Biochem Biophys Res Commun; 2021 Jul; 561():7-13. PubMed ID: 33992835
[TBL] [Abstract][Full Text] [Related]
19. Disrupted hippocampal growth hormone secretagogue receptor 1α interaction with dopamine receptor D1 plays a role in Alzheimer's disease.
Tian J; Guo L; Sui S; Driskill C; Phensy A; Wang Q; Gauba E; Zigman JM; Swerdlow RH; Kroener S; Du H
Sci Transl Med; 2019 Aug; 11(505):. PubMed ID: 31413143
[TBL] [Abstract][Full Text] [Related]
20. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
Liu B; Liu J; Wang JG; Liu CL; Yan HJ
Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
